Featured Research

from universities, journals, and other organizations

Detailed assessment of heart failure identifies patients needing pacemaker treatment

Date:
June 10, 2014
Source:
Ume University
Summary:
By measuring how synchronized the heart chambers work together, it is possible to identify which patients with heart failure who benefit from pacemaker therapy, and which ones who do not. Heart failure is not only a health problem for the patient but also an economic problem for society, since a large proportion of the patients have persistent symptoms like shortness of breath, fatigue, swollen legs, etc., despite that they receive treatment.

By measuring how synchronized the heart chambers work together, it is possible to identify which patients with heart failure who benefit from pacemaker therapy, and which ones who do not. This is presented in a thesis to be defended by Gani Bajraktari on 10 June at Ume University in Sweden.

Heart failure is not only a health problem for the patient but also an economic problem for society, since a large proportion of the patients have persistent symptoms like shortness of breath, fatigue, swollen legs, etc., despite that they receive treatment. Many patients get resynchronisation treatment, CRT, which means that an advanced pacemaker, which sends small, undetectable electrical impulses to both lower chambers of the heart, helps them to beat together in a more synchronized pattern. This improves the heart's ability to pump blood and oxygen to the body.

CRT treatment increases survival among these patients and provides in many cases a good result, but despite this, nearly 30 percent of the patients do not respond favourably. Identifying those patients has been a subject of interest for many years, but so far, research has only shown modest results.

Gani Bajraktari has studied the usefulness of measuring total isovolumic time, t- IVT, which is a measure of the short time during the heart cycle, during which the ventricle is neither filling or ejection blood.

His thesis shows that t-IVT is a significant independent factor for the patient's exercise capacity, clinical well-being and response to CRT. This result is independent of whether the patient has heart failure or not, the heart's pumping capacity, and presence of atrial fibrillation. By using t- IVT to identify patients likely to benefit from treatment with CRT, Gani Bajraktari considers that it is possible to optimise the selection of patients, protecting patients from unnecessary high-risk treatment and also reduce the cost of this treatment.

"The thesis shows that there is great value in measuring t-IVT using echocardiography in clinical practice," says Gani Bajraktari. "It's very important to measure t-IVT as it makes it possible to identify which patients with heart failure who benefit from resynchronization treatment and which who do not benefit. Today, far too many patients are getting CRT without detectable benefit."

Link to full dissertation: http://umu.diva-portal.org/smash/record.jsf?pid=diva2:718105


Story Source:

The above story is based on materials provided by Ume University. Note: Materials may be edited for content and length.


Cite This Page:

Ume University. "Detailed assessment of heart failure identifies patients needing pacemaker treatment." ScienceDaily. ScienceDaily, 10 June 2014. <www.sciencedaily.com/releases/2014/06/140610101846.htm>.
Ume University. (2014, June 10). Detailed assessment of heart failure identifies patients needing pacemaker treatment. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2014/06/140610101846.htm
Ume University. "Detailed assessment of heart failure identifies patients needing pacemaker treatment." ScienceDaily. www.sciencedaily.com/releases/2014/06/140610101846.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins